Skip to main content
SpringerLink
Log in

Spezielle Infektionen

  • Chapter
Repetitorium Intensivmedizin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Ausgewählte Literatur

Publikationen

  • Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2009 im Internet

    Google Scholar 

  • Arendrup MC (2010) Epidemiology of invasive candidiasis. Curr Opin Crit Care 16:445–452

    Article  PubMed  Google Scholar 

  • Attygalle D, Rodrigo N (2004) New trends in the management of tetanus. Expert Rev Anti Infect Ther 2:73–84

    Article  CAS  PubMed  Google Scholar 

  • Barker J, Travers S (2002) Case report: an 11-year-old girl with tetany. Curr Opin Pediatr 14:338–342

    Article  PubMed  Google Scholar 

  • Barth R (2010) Hohe Erfolgsrate bei schwer kranken Patienten mit Candidämie. Kongressbericht von der 44. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e.V. Tagung. Klinikarzt 10

    Google Scholar 

  • Bartlett JG, Perl TM (2005) The new clostridium diffice – what does it mean? N Engl J Med 353:2503–2505

    Article  CAS  PubMed  Google Scholar 

  • Battegay M, Flückiger U (2003) Therapie schwerer Pilzinfektionen. Internist (Berl) 44:1549–1556

    Article  CAS  Google Scholar 

  • Beekmann SE (1999) Unfinished business: Assessing the efficacy of extraluminal silver ions on the prevention of microbial colonization and catheter-associated infection. Crit Care Med 27:456–458

    Article  CAS  PubMed  Google Scholar 

  • Begg et al (1999) Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. J Infect 39:1–15

    Article  CAS  PubMed  Google Scholar 

  • Böhme A, Ruhnke M, Bushheidt D, Cornely OA et al (2008) Treatmenz of invasive fungal infections in cancer patients – recommendations of the infectious diseases working party (AGIHO) of the German Society of Hematology and oncology (DGHO). Ann Hematol 88:97–110

    Article  PubMed  Google Scholar 

  • Borg-von Zepelin M et al. (2007) Epidemiology and antifugal susceptibiliies of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July (2004) to August 2005. JAC 60:424–428

    Google Scholar 

  • Rüchel R, Debusmann F (2008) Serologie in der Diagnostik von Mykosen. Chemotherapie Journal 17:264–266

    Google Scholar 

  • Cook TM, Protheroe RT, Handel JM (2001) Tetanus: a review of the literature. Br J Anaesth 87:477–487

    Article  CAS  PubMed  Google Scholar 

  • Cornely OA, Maertens J, Winston DJ et al (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348–359

    Article  CAS  PubMed  Google Scholar 

  • Daum RS et al (2001) Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall. Crit Care Med 29(Suppl):92–96

    Article  Google Scholar 

  • Debusmann F et al (2008) Serologische Candida-Diagnostik: Vergleich von drei Antigentests. Mikrobiologie 18:261–262

    Google Scholar 

  • De Gans J, van de Beek D (2002) The European Dexamethasone in adulthood bacterial meningitis study investigation. New Engl J Med 347:154–9

    Article  Google Scholar 

  • Drew RH, Arthur RR, Perfect JR (2005) Is it time to abandon the use of Amphotericin B bladder irrigation? Clin Infect Dis 40:1465–1470

    Article  PubMed  Google Scholar 

  • Eckmanns T (2004) Hygienische Maßnahmen bei MRSA. J Anästhesie Intensivbehandlung 2:2–6

    Google Scholar 

  • Eggimann P et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072

    Article  CAS  PubMed  Google Scholar 

  • Engel C et al. (2007) Intensive Care Med 33: 606–18

    Google Scholar 

  • Engrand N, Van De Perre P, Vilain G et al (2001) Intrathecal baclofen for severe tetanus in a pregnant woman. Eur J Anaesthesiol 18:261–263

    Article  CAS  PubMed  Google Scholar 

  • Epidemiologieches Bulletin vom Robert-Kock-Institut (RKI) 2004; Nr. 46

    Google Scholar 

  • Empfehlungen zur Prävention und Kontrolle von methicillinresistenten Staphylococcus aureus (MRSA)-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen (1999) Bundesgesundheitsblatt 42:954–958

    Google Scholar 

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) - Guidelines for diagnosis and management of Candida Diseases 2012 (online-Publikation); www.escmid.org

    Google Scholar 

  • Fridkin SK et al (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. NEJM 352:1436–1444

    Article  CAS  PubMed  Google Scholar 

  • Füssle R (2012) Invasive Pilzinfektionen bei kritisch kranken Patienten. Anästh Intensivmed 53:523–537

    Google Scholar 

  • Garey KW et al (2006) Time of initiating of fluconazol therapy impacts mortality in patients with candidemia: a multi. institutional study. Clin Infec Dis 43:25–31

    Article  CAS  Google Scholar 

  • Gartner R (2003) Tetanus. Internist (Berl) 44:1237–1242

    Article  CAS  Google Scholar 

  • Geffers C et al. (2004) Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections

    Google Scholar 

  • Surveillance System (KISS). Anasthesiol Intensivmed Notfallmed Schmerzther 39: 15–19

    Google Scholar 

  • Geldner G et al (1999) Therapie und Prophylaxe bei MRSAInfektion auf Intensivstationen. Intensivmedizin 36:612–618

    Article  Google Scholar 

  • Gemeinsame Empfehlungen der deutschsprachigen mykologischen Gesellschaft (DMYKG) und der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) (2011) Diagnose und Therapie von Candida-Infektionen. Chemother J 20:67–93

    Google Scholar 

  • Glöckner A (2011) Innovative Antimykotika zur Therapie invasiver Pilzinfektionen. Internist (Berl) 52:1118–1126

    Article  Google Scholar 

  • Guery BP, Arendrup MC, Auzinger G et al (2009) Management of invasive candidiasis and candidemia in adult non neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 35:55–62

    Article  PubMed  Google Scholar 

  • Guery BP, Arendrup MC, Auzinger G et al (2009) Management of invasive candidiasis and candidemia in adult nonneutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med 35:206–214

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez P et al (1999) Reduction of catheter-associated central line sepsis in a burn unit: A new methode of catheter care. Crit Care Med 27(Suppl):140–A

    Article  Google Scholar 

  • Groll HA et al (2011) Diagnose und Therapie der Candida-Infektionen Gemeinsame Empfehlung der deutschsprachigen Mykologischen Gesellschaft (DMYKG) und der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG). Chemother J 20:67–93

    CAS  Google Scholar 

  • Heizmann WR et al. (2004) Vademecum Infektiologie 2003/2004. Wyeth GmbH, Münster

    Google Scholar 

  • Herbrecht et al. for the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group (2002) Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis. New Engl J Med 347:408–415

    Google Scholar 

  • Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415

    Article  CAS  PubMed  Google Scholar 

  • Hidron AI, Edwards JR et al (2008) Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections. Infect Control Hosp Epidemiol 29:996–1011

    Article  PubMed  Google Scholar 

  • Klamareck K, Rosenthal E (2005) Therapie häufiger Infektionen in der täglichen Praxis. Eine Anleitung. Klinikarzt 34:6

    Google Scholar 

  • Kluge S (2009). Pilzinfektionen auf der Intensivstation. Lunch-Symposium. 41. Jahrestagung der Deutschen Gesellschaft für internistische Intensivmedizin und Notfallmedizin. Hamburg 10.-13. Juni 2009

    Google Scholar 

  • Koch S et al (2005) Diagnostik und Therapie invasiver Pilzinfektionen auf der Intensivstation. Anaesthesist 54:1047–1066

    Article  CAS  PubMed  Google Scholar 

  • Kohler A, Schaller P (2001) Tetanus–differential diagnosis of cerebrovascular stroke. Schweiz Rundsch Med Prax 90:643–646

    CAS  Google Scholar 

  • Leon C, Ruiz-Santana S, Saavedra P et al (2009) Usefulness of the »Candida score« for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633

    Article  PubMed  Google Scholar 

  • Lichtenstein C et al (2010) Update: Invasive Pilzinfektion. Diagnose und Therapie in der operativen Intensivmedizin. Der Anästhesist 59:30–52

    Article  Google Scholar 

  • Linder MW et al (1987) Der Mannheimer Peritonitis-Index. Ein Instrument zur intraoperativen Prognose der Peritonitis. Chirurg 58:84–92

    CAS  PubMed  Google Scholar 

  • Lode M, Reiner CR (2004) Therapie der Osteomyelitis Zeitschrift für Chemotherapie 25: 33–36

    Google Scholar 

  • Loo VG et al (2005) A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. New Engl J Med 353:2442–2449

    Article  CAS  PubMed  Google Scholar 

  • Lottermoser K et al (2001) Fifty-three year old patient with tetany. Internist (Berl) 42:1413–1417

    Article  CAS  Google Scholar 

  • Maertens J, Theunissen K, Verhoef G et al (2005) Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 41:1242–1250

    Article  CAS  PubMed  Google Scholar 

  • Maki DG, Weise CE, Sarafin HW (1977) A semiquantitave culture method of identifying intravenous-catheterrelated infection. N Engl J Med 296:1305–1309

    Article  CAS  PubMed  Google Scholar 

  • Maschmeyer G, Ruhnke M (2002) Arzneimitteltherapie invasiver Candida- und Aspergillusinfektionen. Internist (Berl) 43:1464–1476

    Article  CAS  Google Scholar 

  • McDonald LC et al (2005) An epidemic, toxin gene-variant strain of clostridium difficile. New Engl J Med 353:2433–2441

    Article  CAS  PubMed  Google Scholar 

  • McGee DC et al (2003) Preventing complications of central venous catheterization. New Engl J Med 348:1123–1133

    Article  PubMed  Google Scholar 

  • Meersseman W, Lagrou K, Maertens J et al (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177:27–34

    Article  PubMed  Google Scholar 

  • Menzin J. Meyer JL Friedman M et al (2009) Mortality, length of hospitalization and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm 66:1711–1717

    Article  PubMed  Google Scholar 

  • Moller K et al (2000) Guidelines for managing acute bacterial meningitis. BMJ 320:129–0

    Article  Google Scholar 

  • Mora-Duarte J for the Caspofungin Invasive Candidiasis Study Group (2002) Comparison of caspofungin and amphotericin b for invasive candidiasis. New Engl J Med 347:2020–2029

    Google Scholar 

  • Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 :3640–3645

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pappas PG et al (2009) Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the infectious diseases Society of America. Clinical Infect Dis 2009 48:503–535

    Article  CAS  Google Scholar 

  • Pappas PG, Rotstein CM, Betts RF et al (2007) Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 45:883–893

    Article  CAS  PubMed  Google Scholar 

  • Parkins MD, Sabuda DM, Elsayed S, Laupland KB (2007) Adequacy of emperial antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60:613–618

    Article  CAS  PubMed  Google Scholar 

  • Pascual A, Calandra T, Bolay S et al (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 46:201–211

    Article  CAS  PubMed  Google Scholar 

  • Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Quagliarello V et al (1997) Treatment of bacterial meningitis. N Engl J Med 336:708–716

    Article  CAS  PubMed  Google Scholar 

  • Quintel M et al (2003) Infektionskrankheiten in der Intensivmedizin, 1. Aufl. Uni-Med, Bremen

    Google Scholar 

  • Reboli AC, Rotstein C, Pappas PG et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472–2482

    Article  CAS  PubMed  Google Scholar 

  • Rimek D (2005) Wertigkeit des Aspergillus-Galaktomannan-Antigen-Nachweises zur Diagnostik invasiver Aspergillosen. Mikrobiologe 2:7–2

    Google Scholar 

  • Robert-Koch-Institut. www.rki.de. Empfehlungen der Kommission für Krankenhaushygiene und Infektionsprävention

    Google Scholar 

  • Romitti M, Romitti F, Banchini E (2000) Tetanus. Physiopathology and intensive care treatment. Minerva Anestesiol 66:445–460

    Google Scholar 

  • Siegmund-Schultze N (2011) Therapie der Clostridium-difficile-Infektion: Weniger Rückfälle durch Schmalspektrum-Makrolid. Dtsch Ärztebl 108: A-456/B-367/C–367

    Google Scholar 

  • Senn L, Robinson JO, Schmidt S et al (2008) 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46:878–885

    Article  CAS  PubMed  Google Scholar 

  • Trampitsch E, Krumpholz R, Likar R et al. (2000) Continuous intrathecal administration of baclofen in severe tetanus. Anasthesiol Intensivmed Notfallmed Schmerzther 35:532–533

    Google Scholar 

  • Trunkel AR, Scheid WM (2002) Editorial: Corticoid for everyone with meningitis? New Engl J Med 347:1613

    Article  Google Scholar 

  • Ullmann AJ, Lipton JH, Vesole DH et al (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:335–347

    Article  CAS  PubMed  Google Scholar 

  • Wacha H et al (2000) Antibiotikatherapie bei Peritonitis. J Anästhesie Intensivmed 1:223–226

    Google Scholar 

  • Walsh TJ (2002) Echinocandins – An advance in the primary treatment of invasive candidiasis. New Engl J Med 347:2070–2072

    Article  PubMed  Google Scholar 

  • Walsh TJ for the National Institute of Allergy and Infectious Diseases Mycoses Study Group (2002) Voriconazole compared with liposomal Amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. New Engl J Med 346:225–234

    Article  CAS  PubMed  Google Scholar 

  • Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360

    Article  CAS  PubMed  Google Scholar 

  • Wisplinghoff H et al (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317

    Article  PubMed  Google Scholar 

  • Wernitz MH (2005) Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clinical Microbiol Infect 11:457–465

    Article  CAS  Google Scholar 

  • Wernitz MH (2005) Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clinical Microbiol Infect 11:466–471

    Article  CAS  Google Scholar 

  • Wernitz MH (2006) Screening bei stationärer Aufnahme von Risikopatienten für die Kolonisation oder Infektion mit Methicillin-resistentem Staphylococcus aureus (MRSA). Eine Kohortenstudie über den Einfluss des Screenings auf die Häufigkeit nosokominaler MRSA-Infektionen mit einer Kostenanalyse vor dem Hintergrund des deutschen DRG-Fallpauschalen-Vergütungssystems. www.diss. fu-berlin.de/2006/607

    Google Scholar 

Internetadressen

Download references

Author information

Authors and Affiliations

  1. Marienhaus Klinikum Bendorf – Neuwied – Waldbreitbach, Neuwied

    Dr. Michael Fresenius

Authors
  1. Dr. Michael Fresenius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fresenius, M. (2014). Spezielle Infektionen. In: Repetitorium Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-44933-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-44933-8_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-44932-1

  • Online ISBN: 978-3-642-44933-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation